Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 138 entries
Sorted by: Best Match Show Resources per page
SU-D-213AB-03: Design Optimization of a HDR Ir-192 Brachytherapy Skin Applicator Using Monte Carlo-Based Dosimetry.

Medical physics

Yang Y, Rivard MJ.
PMID: 28517379
Med Phys. 2012 Jun;39(6):3612. doi: 10.1118/1.4734663.

PURPOSE: AccuBoost® applicators are designed to deliver boost dose after whole breast irradiation in substitution for electron boost. By augmenting the current design through adding a wedge inside the applicator and atungsten window above the skin surface, the AccuBoost...

Cite
Yang Y, Rivard MJ. SU-D-213AB-03: Design Optimization of a HDR Ir-192 Brachytherapy Skin Applicator Using Monte Carlo-Based Dosimetry. Med Phys. 2012;39(6):3612doi: 10.1118/1.4734663.
Yang, Y., & Rivard, M. J. (2012). SU-D-213AB-03: Design Optimization of a HDR Ir-192 Brachytherapy Skin Applicator Using Monte Carlo-Based Dosimetry. Medical physics, 39(6), 3612. https://doi.org/10.1118/1.4734663
Yang, Y, and Rivard, M J. "SU-D-213AB-03: Design Optimization of a HDR Ir-192 Brachytherapy Skin Applicator Using Monte Carlo-Based Dosimetry." Medical physics vol. 39,6 (2012): 3612. doi: https://doi.org/10.1118/1.4734663
Yang Y, Rivard MJ. SU-D-213AB-03: Design Optimization of a HDR Ir-192 Brachytherapy Skin Applicator Using Monte Carlo-Based Dosimetry. Med Phys. 2012 Jun;39(6):3612. doi: 10.1118/1.4734663. PMID: 28517379.
Copy Download .nbib Format: NLM
Response to "Comment on 'Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations' " [Med. Phys. 31, 633-674 (2004)].

Medical physics

Rivard MJ, Butler WM, DeWerd LA, Huq MS, Ibbott GS, Melhus CS, Mitch MG, Nath R, Williamson JJ.
PMID: 28513947
Med Phys. 2005 Jun;32(6):1822-1824. doi: 10.1118/1.1905824.

No abstract available.

Cite
Rivard MJ, Butler WM, DeWerd LA, et al. Response to "Comment on 'Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations' " [Med. Phys. 31, 633-674 (2004)]. Med Phys. 2005;32(6):1822-1824doi: 10.1118/1.1905824.
Rivard, M. J., Butler, W. M., DeWerd, L. A., Huq, M. S., Ibbott, G. S., Melhus, C. S., Mitch, M. G., Nath, R., & Williamson, J. J. (2005). Response to "Comment on 'Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations' " [Med. Phys. 31, 633-674 (2004)]. Medical physics, 32(6), 1822-1824. https://doi.org/10.1118/1.1905824
Rivard, Mark J, et al. "Response to "Comment on 'Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations' " [Med. Phys. 31, 633-674 (2004)]." Medical physics vol. 32,6 (2005): 1822-1824. doi: https://doi.org/10.1118/1.1905824
Rivard MJ, Butler WM, DeWerd LA, Huq MS, Ibbott GS, Melhus CS, Mitch MG, Nath R, Williamson JJ. Response to "Comment on 'Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations' " [Med. Phys. 31, 633-674 (2004)]. Med Phys. 2005 Jun;32(6):1822-1824. doi: 10.1118/1.1905824. PMID: 28513947.
Copy Download .nbib Format: NLM
Acceptability, Adaptation, and Clinical Outcomes of Acupuncture Provided in the Emergency Department: A Retrospective Pilot Study.

Pain medicine (Malden, Mass.)

Reinstein AS, Erickson LO, Griffin KH, Rivard RL, Kapsner CE, Finch MD, Dusek JA.
PMID: 26917627
Pain Med. 2017 Jan 30;18(1):169-178. doi: 10.1093/pm/pnv114.

OBJECTIVE: To evaluate acceptability and clinical outcomes of acupuncture on patient-reported pain and anxiety in an emergency department (ED).DESIGN: Observational, retrospective pilot study.SETTING: Abbott Northwestern Hospital ED, Minneapolis, MN.METHODS: Retrospective data was used to identify patients receiving acupuncture in...

Cite
Reinstein AS, Erickson LO, Griffin KH, et al. Acceptability, Adaptation, and Clinical Outcomes of Acupuncture Provided in the Emergency Department: A Retrospective Pilot Study. Pain Med. 2017;18(1):169-178doi: 10.1093/pm/pnv114.
Reinstein, A. S., Erickson, L. O., Griffin, K. H., Rivard, R. L., Kapsner, C. E., Finch, M. D., & Dusek, J. A. (2017). Acceptability, Adaptation, and Clinical Outcomes of Acupuncture Provided in the Emergency Department: A Retrospective Pilot Study. Pain medicine (Malden, Mass.), 18(1), 169-178. https://doi.org/10.1093/pm/pnv114
Reinstein, Adam S, et al. "Acceptability, Adaptation, and Clinical Outcomes of Acupuncture Provided in the Emergency Department: A Retrospective Pilot Study." Pain medicine (Malden, Mass.) vol. 18,1 (2017): 169-178. doi: https://doi.org/10.1093/pm/pnv114
Reinstein AS, Erickson LO, Griffin KH, Rivard RL, Kapsner CE, Finch MD, Dusek JA. Acceptability, Adaptation, and Clinical Outcomes of Acupuncture Provided in the Emergency Department: A Retrospective Pilot Study. Pain Med. 2017 Jan 30;18(1):169-178. doi: 10.1093/pm/pnv114. PMID: 26917627; PMCID: PMC4999344.
Copy Download .nbib Format: NLM
Evaluation of BEBIG HDR (60)Co system for non-invasive image-guided breast brachytherapy.

Journal of contemporary brachytherapy

Zehtabian M, Sina S, Rivard MJ, Meigooni AS.
PMID: 26816504
J Contemp Brachytherapy. 2015 Dec;7(6):469-78. doi: 10.5114/jcb.2015.56766. Epub 2015 Dec 30.

PURPOSE: HDR (60)Co system has recently been developed and utilized for brachytherapy in many countries outside of the U.S. as an alternative to (192)Ir. In addition, the AccuBoost(®) technique has been demonstrated to be a successful non-invasive image-guided breast...

Cite
Zehtabian M, Sina S, Rivard MJ, et al. Evaluation of BEBIG HDR (60)Co system for non-invasive image-guided breast brachytherapy. J Contemp Brachytherapy. 2015;7(6):469-78doi: 10.5114/jcb.2015.56766.
Zehtabian, M., Sina, S., Rivard, M. J., & Meigooni, A. S. (2015). Evaluation of BEBIG HDR (60)Co system for non-invasive image-guided breast brachytherapy. Journal of contemporary brachytherapy, 7(6), 469-78. https://doi.org/10.5114/jcb.2015.56766
Zehtabian, Mehdi, et al. "Evaluation of BEBIG HDR (60)Co system for non-invasive image-guided breast brachytherapy." Journal of contemporary brachytherapy vol. 7,6 (2015): 469-78. doi: https://doi.org/10.5114/jcb.2015.56766
Zehtabian M, Sina S, Rivard MJ, Meigooni AS. Evaluation of BEBIG HDR (60)Co system for non-invasive image-guided breast brachytherapy. J Contemp Brachytherapy. 2015 Dec;7(6):469-78. doi: 10.5114/jcb.2015.56766. Epub 2015 Dec 30. PMID: 26816504; PMCID: PMC4716133.
Copy Download .nbib Format: NLM
Partnering With VA Stakeholders to Develop a Comprehensive Patient Safety Data Display: Lessons Learned From the Field.

American journal of medical quality : the official journal of the American College of Medical Quality

Chen Q, Shin MH, Chan JA, Sullivan JL, Borzecki AM, Shwartz M, Rivard PE, Hatoun J, Rosen AK.
PMID: 25500716
Am J Med Qual. 2016 Mar-Apr;31(2):178-86. doi: 10.1177/1062860614560214. Epub 2014 Dec 10.

Health care systems are increasingly burdened by the large numbers of safety measures currently being reported. Within the Veterans Administration (VA), most safety reporting occurs within organizational silos, with little involvement by the frontline users of these measures. To...

Cite
Chen Q, Shin MH, Chan JA, et al. Partnering With VA Stakeholders to Develop a Comprehensive Patient Safety Data Display: Lessons Learned From the Field. Am J Med Qual. 2014;31(2):178-86doi: 10.1177/1062860614560214.
Chen, Q., Shin, M. H., Chan, J. A., Sullivan, J. L., Borzecki, A. M., Shwartz, M., Rivard, P. E., Hatoun, J., & Rosen, A. K. (2016). Partnering With VA Stakeholders to Develop a Comprehensive Patient Safety Data Display: Lessons Learned From the Field. American journal of medical quality : the official journal of the American College of Medical Quality, 31(2), 178-86. https://doi.org/10.1177/1062860614560214
Chen, Qi, et al. "Partnering With VA Stakeholders to Develop a Comprehensive Patient Safety Data Display: Lessons Learned From the Field." American journal of medical quality : the official journal of the American College of Medical Quality vol. 31,2 (2016): 178-86. doi: https://doi.org/10.1177/1062860614560214
Chen Q, Shin MH, Chan JA, Sullivan JL, Borzecki AM, Shwartz M, Rivard PE, Hatoun J, Rosen AK. Partnering With VA Stakeholders to Develop a Comprehensive Patient Safety Data Display: Lessons Learned From the Field. Am J Med Qual. 2016 Mar-Apr;31(2):178-86. doi: 10.1177/1062860614560214. Epub 2014 Dec 10. PMID: 25500716.
Copy Download .nbib Format: NLM
Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases.

OncoTargets and therapy

He Y, Sun W, Wang Y, Ren S, Li X, Li J, Rivard CJ, Zhou C, Hirsch FR.
PMID: 27143936
Onco Targets Ther. 2016 Apr 21;9:2409-14. doi: 10.2147/OTT.S102236. eCollection 2016.

OBJECTIVE: Brain metastases occur in one-third of all non-small-cell lung cancer patients. Due to restrictive transport at the blood-brain barrier, many drugs provide poor control of metastases in the brain. The aim of this study was to compare erlotinib...

Cite
He Y, Sun W, Wang Y, et al. Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases. Onco Targets Ther. 2016;9:2409-14doi: 10.2147/OTT.S102236.
He, Y., Sun, W., Wang, Y., Ren, S., Li, X., Li, J., Rivard, C. J., Zhou, C., & Hirsch, F. R. (2016). Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases. OncoTargets and therapy, 92409-14. https://doi.org/10.2147/OTT.S102236
He, Yayi, et al. "Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases." OncoTargets and therapy vol. 9 (2016): 2409-14. doi: https://doi.org/10.2147/OTT.S102236
He Y, Sun W, Wang Y, Ren S, Li X, Li J, Rivard CJ, Zhou C, Hirsch FR. Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases. Onco Targets Ther. 2016 Apr 21;9:2409-14. doi: 10.2147/OTT.S102236. eCollection 2016. PMID: 27143936; PMCID: PMC4844452.
Copy Download .nbib Format: NLM
SpineCor treatment for Juvenile Idiopathic Scoliosis: SOSORT award 2010 winner.

Scoliosis

Coillard C, Circo AB, Rivard CH.
PMID: 21067608
Scoliosis. 2010 Nov 10;5:25. doi: 10.1186/1748-7161-5-25.

INTRODUCTION: Juvenile idiopathic scoliosis is a condition used to describe patients who are least 4 years of age but younger than 10 when the deformity is first identified. In these patients, the condition is usually progressive and those that...

Cite
Coillard C, Circo AB, Rivard CH. SpineCor treatment for Juvenile Idiopathic Scoliosis: SOSORT award 2010 winner. Scoliosis. 2010;5:25doi: 10.1186/1748-7161-5-25.
Coillard, C., Circo, A. B., & Rivard, C. H. (2010). SpineCor treatment for Juvenile Idiopathic Scoliosis: SOSORT award 2010 winner. Scoliosis, 525. https://doi.org/10.1186/1748-7161-5-25
Coillard, Christine, et al. "SpineCor treatment for Juvenile Idiopathic Scoliosis: SOSORT award 2010 winner." Scoliosis vol. 5 (2010): 25. doi: https://doi.org/10.1186/1748-7161-5-25
Coillard C, Circo AB, Rivard CH. SpineCor treatment for Juvenile Idiopathic Scoliosis: SOSORT award 2010 winner. Scoliosis. 2010 Nov 10;5:25. doi: 10.1186/1748-7161-5-25. PMID: 21067608; PMCID: PMC2989306.
Copy Download .nbib Format: NLM
Grafting Tomato to Manage Bacterial Wilt Caused by Ralstonia solanacearum in the Southeastern United States.

Plant disease

Rivard CL, O'Connell S, Peet MM, Welker RM, Louws FJ.
PMID: 30727209
Plant Dis. 2012 Jul;96(7):973-978. doi: 10.1094/PDIS-12-10-0877.

Bacterial wilt, caused by Ralstonia solanacearum, can result in severe losses to tomato (Solanum lycopersicum) growers in the southeastern United States, and grafting with resistant rootstocks may be an effective strategy for managing this disease. However, R. solanacearum populations...

Cite
Rivard CL, O'Connell S, Peet MM, et al. Grafting Tomato to Manage Bacterial Wilt Caused by Ralstonia solanacearum in the Southeastern United States. Plant Dis. 2012;96(7):973-978doi: 10.1094/PDIS-12-10-0877.
Rivard, C. L., O'Connell, S., Peet, M. M., Welker, R. M., & Louws, F. J. (2012). Grafting Tomato to Manage Bacterial Wilt Caused by Ralstonia solanacearum in the Southeastern United States. Plant disease, 96(7), 973-978. https://doi.org/10.1094/PDIS-12-10-0877
Rivard, C L, et al. "Grafting Tomato to Manage Bacterial Wilt Caused by Ralstonia solanacearum in the Southeastern United States." Plant disease vol. 96,7 (2012): 973-978. doi: https://doi.org/10.1094/PDIS-12-10-0877
Rivard CL, O'Connell S, Peet MM, Welker RM, Louws FJ. Grafting Tomato to Manage Bacterial Wilt Caused by Ralstonia solanacearum in the Southeastern United States. Plant Dis. 2012 Jul;96(7):973-978. doi: 10.1094/PDIS-12-10-0877. PMID: 30727209.
Copy Download .nbib Format: NLM
[No title available]

Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec

Leclerc AM, Vézeau-Beaulieu K, Rivard MC, Miquelon P.
PMID: 29702762
Perspect Infirm. 2018 May-Jun;15(3):50-53.

No abstract available.

Cite
Leclerc AM, Vézeau-Beaulieu K, Rivard MC, et al. Sécurisation culturelle en santé : un concept émergent. . Perspect Infirm. 2018;15(3):50-53
Leclerc, A. M., Vézeau-Beaulieu, K., Rivard, M. C., & Miquelon, P. (2018). Sécurisation culturelle en santé : un concept émergent. . Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec, 15(3), 50-53.
Leclerc, Anne-Marie, et al. "Sécurisation culturelle en santé : un concept émergent." . Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec vol. 15,3 (2018): 50-53.
Leclerc AM, Vézeau-Beaulieu K, Rivard MC, Miquelon P. Sécurisation culturelle en santé : un concept émergent. . Perspect Infirm. 2018 May-Jun;15(3):50-53. French. PMID: 29702762.
Copy Download .nbib Format: NLM
Micro-scale heterogeneity of soil phosphorus depends on soil substrate and depth.

Scientific reports

Werner F, Mueller CW, Thieme J, Gianoncelli A, Rivard C, Höschen C, Prietzel J.
PMID: 28600571
Sci Rep. 2017 Jun 09;7(1):3203. doi: 10.1038/s41598-017-03537-8.

Soils comprise various heterogeneously distributed pools of lithogenic, free organic, occluded, adsorbed, and precipitated phosphorus (P) forms, which differ depending on soil forming factors. Small-scale heterogeneity of element distributions recently has received increased attention in soil science due to...

Cite
Werner F, Mueller CW, Thieme J, et al. Micro-scale heterogeneity of soil phosphorus depends on soil substrate and depth. Sci Rep. 2017;7(1):3203doi: 10.1038/s41598-017-03537-8.
Werner, F., Mueller, C. W., Thieme, J., Gianoncelli, A., Rivard, C., Höschen, C., & Prietzel, J. (2017). Micro-scale heterogeneity of soil phosphorus depends on soil substrate and depth. Scientific reports, 7(1), 3203. https://doi.org/10.1038/s41598-017-03537-8
Werner, Florian, et al. "Micro-scale heterogeneity of soil phosphorus depends on soil substrate and depth." Scientific reports vol. 7,1 (2017): 3203. doi: https://doi.org/10.1038/s41598-017-03537-8
Werner F, Mueller CW, Thieme J, Gianoncelli A, Rivard C, Höschen C, Prietzel J. Micro-scale heterogeneity of soil phosphorus depends on soil substrate and depth. Sci Rep. 2017 Jun 09;7(1):3203. doi: 10.1038/s41598-017-03537-8. PMID: 28600571; PMCID: PMC5466645.
Copy Download .nbib Format: NLM
Hemophilia prophylaxis adherence and bleeding using a tailored, frequency-escalated approach: The Canadian Hemophilia Primary Prophylaxis Study.

Research and practice in thrombosis and haemostasis

Dover S, Blanchette VS, Wrathall D, Pullenayegum E, Kazandjian D, Song B, Hawes SA, Cloutier S, Rivard GE, Klaassen RJ, Paradis E, Laferriere N, Stain AM, Chan AK, Israels SJ, Sinha R, Steele M, Wu JKM, Feldman BM.
PMID: 32110763
Res Pract Thromb Haemost. 2020 Jan 29;4(2):318-325. doi: 10.1002/rth2.12301. eCollection 2020 Feb.

BACKGROUND: Standard of care for persons with severe hemophilia A includes regular replacement of factor VIII (FVIII). Prophylaxis regimens using standard half-life (SHL) FVIII concentrates, while effective, are costly and require frequent intravenous infusions.AIM: This study evaluated the adherence...

Cite
Dover S, Blanchette VS, Wrathall D, et al. Hemophilia prophylaxis adherence and bleeding using a tailored, frequency-escalated approach: The Canadian Hemophilia Primary Prophylaxis Study. Res Pract Thromb Haemost. 2020;4(2):318-325doi: 10.1002/rth2.12301.
Dover, S., Blanchette, V. S., Wrathall, D., Pullenayegum, E., Kazandjian, D., Song, B., Hawes, S. A., Cloutier, S., Rivard, G. E., Klaassen, R. J., Paradis, E., Laferriere, N., Stain, A. M., Chan, A. K., Israels, S. J., Sinha, R., Steele, M., Wu, J. K. M., & Feldman, B. M. (2020). Hemophilia prophylaxis adherence and bleeding using a tailored, frequency-escalated approach: The Canadian Hemophilia Primary Prophylaxis Study. Research and practice in thrombosis and haemostasis, 4(2), 318-325. https://doi.org/10.1002/rth2.12301
Dover, Saunya, et al. "Hemophilia prophylaxis adherence and bleeding using a tailored, frequency-escalated approach: The Canadian Hemophilia Primary Prophylaxis Study." Research and practice in thrombosis and haemostasis vol. 4,2 (2020): 318-325. doi: https://doi.org/10.1002/rth2.12301
Dover S, Blanchette VS, Wrathall D, Pullenayegum E, Kazandjian D, Song B, Hawes SA, Cloutier S, Rivard GE, Klaassen RJ, Paradis E, Laferriere N, Stain AM, Chan AK, Israels SJ, Sinha R, Steele M, Wu JKM, Feldman BM. Hemophilia prophylaxis adherence and bleeding using a tailored, frequency-escalated approach: The Canadian Hemophilia Primary Prophylaxis Study. Res Pract Thromb Haemost. 2020 Jan 29;4(2):318-325. doi: 10.1002/rth2.12301. eCollection 2020 Feb. PMID: 32110763; PMCID: PMC7040543.
Copy Download .nbib Format: NLM
Amplified fragment length polymorphism analysis supports the valid separate species status of .

Forensic sciences research

Picard CJ, Wells JD, Ullyot A, Rognes K.
PMID: 30483652
Forensic Sci Res. 2017 Dec 08;3(1):60-64. doi: 10.1080/20961790.2017.1398286. eCollection 2018.

Common DNA-based species determination methods fail to distinguish some blow flies in the forensically and medically important genus

Cite
Picard CJ, Wells JD, Ullyot A, et al. Amplified fragment length polymorphism analysis supports the valid separate species status of . Forensic Sci Res. 2017;3(1):60-64doi: 10.1080/20961790.2017.1398286.
Picard, C. J., Wells, J. D., Ullyot, A., & Rognes, K. (2018). Amplified fragment length polymorphism analysis supports the valid separate species status of . Forensic sciences research, 3(1), 60-64. https://doi.org/10.1080/20961790.2017.1398286
Picard, Christine J, et al. "Amplified fragment length polymorphism analysis supports the valid separate species status of ." Forensic sciences research vol. 3,1 (2018): 60-64. doi: https://doi.org/10.1080/20961790.2017.1398286
Picard CJ, Wells JD, Ullyot A, Rognes K. Amplified fragment length polymorphism analysis supports the valid separate species status of . Forensic Sci Res. 2017 Dec 08;3(1):60-64. doi: 10.1080/20961790.2017.1398286. eCollection 2018. PMID: 30483652; PMCID: PMC6197086.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 138 entries